GoldenGolden
Advanced Search
CanSino Biologics

CanSino Biologics

CanSino Biologics (CanSinoBIO) is a bio pharmaceutical company primarily producing vaccines.

All edits

Edits on 8 Jun, 2021
Erin Scherfner"prospector:318:157642"
Erin Scherfner edited on 8 Jun, 2021
Edits made to:
Infobox (+3 properties)
Infobox
Country
China
Edits on 14 May, 2021
Dhruv Sharma
Dhruv Sharma edited on 14 May, 2021
Edits made to:
Infobox (+1 properties)
Edits on 12 May, 2021
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 12 May, 2021
Edits made to:
Article (+5/-5 characters)
Article

In April 2020, CanSino Biologics advanced its vaccine candidate candidate, Ad5-nCoV, into PhasePhase II trials (Chinese registration number: ChiCTR2000030906). CanSino Biologics (CanSinoBIO) is collaborating with the National Research Council of Canada (NRC) to advance bioprocessing and clinical development of vaccine candidate against COVID-19, Ad5-nCoV. Ad5-nCoV was co-developed by the Beijing Institute of Biotechnology (BIB) and CanSinoBIO. A genetically engineering replication-defective adenovirus type 5 vector was used to express the SARS-CoV-2 spike protein which is produced in HEK293 cell lines designed and developed at the NRC. As of May 12, 2020, the vaccine is subject to approval by Health Canada for a Clinical Trial Application being filed by CanSinoBIO. As a preparatory step the Government of Canada announced $44 million in funding to support upgrades to NRC facilities in Montreal to ensure readiness for Canadian bioprocessing of potential vaccine candidates.

Golden AI"Funding autocalculation"
Golden AI edited on 12 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Edits on 4 May, 2021
Dushyant Soni
Dushyant Soni edited on 4 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Date incorporated
2009
Edits on 29 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+7 properties)
Infobox
Investors
Edits on 17 Feb, 2021
Golden AI"prospector:155:86332"
Golden AI edited on 17 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Legal classification
Edits on 8 Feb, 2021
Joe Burns
Joe Burns edited on 8 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Legal name
CanSino Biologics, Inc.
Edits on 8 Feb, 2021
Joe Burns"Research engine edit"
Joe Burns edited on 8 Feb, 2021
Edits made to:
Infobox (+1/-1 properties)
Infobox
Edits on 5 Feb, 2021
Joe Burns
Joe Burns edited on 5 Feb, 2021
Edits made to:
Infobox (+4/--1 properties)
Infobox
Number of Employees (ranges)
100 – 249
Stock symbol
CASBF
Edits on 28 Oct, 2020
Golden AI"prospector:29:5039"
Golden AI edited on 28 Oct, 2020
Edits made to:
Infobox (+3 properties)
Infobox
Industry
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
April 19, 2017
Edits on 24 Aug, 2020
Golden AI
Golden AI edited on 24 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Products
Golden AI
Golden AI edited on 24 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Products
Golden AI
Golden AI edited on 24 Aug, 2020
Edits made to:
Infobox (+1 properties)
Golden AI
Golden AI edited on 24 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 24 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 24 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Products
Golden AI
Golden AI edited on 24 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Products
Golden AI
Golden AI edited on 24 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Products
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.